Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurocrine Biosciences
Biotech
Sanofi vaccine vet vaults to GSK—Chutes & Ladders
Sanofi vaccine vet vaults to GSK. Thiel acolyte there and back again at HHS. Formation taps squad of four resident entrepreneurs.
Darren Incorvaia
,
Zoey Becker
Jun 13, 2025 8:30am
Neurocrine hands back 2 CNS gene therapy programs to Voyager
May 7, 2025 7:30am
J&J innovator vaults to Valo—Chutes & Ladders
Apr 11, 2025 8:30am
Harbour spinoff pens $395M deal for preclinical Crenessity rival
Feb 26, 2025 5:14am
Takeda taps Julie Kim as new CEO—Chutes & Ladders
Jan 31, 2025 8:30am
Takeda regains home rights to depression drug from Neurocrine
Jan 28, 2025 4:16am
